The short version
8 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Amantadine Hydrochloride · AMANTADINE HYDROCHLORIDE 50 mg/5mL · Solution · Oral · American Health Packaging
NDC 60687-0797-56 · 10 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE · ANDA · View full market →
8 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Matched to CMS's representative package for this drug (NDC 00121-0646-16) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market · price up 2% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| American Health Packaging | AMANTADINE HYDROCHLORIDE 50 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Atlantic Biologicals Corp. | AMANTADINE HYDROCHLORIDE 50 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Bajaj Medical, Llc | AMANTADINE HYDROCHLORIDE 50 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Cardinal Health 107, LLC | AMANTADINE HYDROCHLORIDE 50 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell Governmental & Specialty RX, LLC. | AMANTADINE HYDROCHLORIDE 100 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC | AMANTADINE HYDROCHLORIDE 100 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC | AMANTADINE HYDROCHLORIDE 50 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| PAI Holdings, LLC dba PAI Pharma | AMANTADINE HYDROCHLORIDE 50 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Patrin Pharma, Inc. | AMANTADINE HYDROCHLORIDE 50 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Amantadine Hydrochloride — NDC 60687-0797-56," retrieved September 3, 2026, https://drugdashboards.com/drug/60687079756.
Free to cite with attribution — see how the data is put together.